Bronchoalveolar levels of plasminogen activator inhibitor-1 and soluble tissue factor are sensitive and specific markers of pulmonary inflammation.

Registros relacionados

• Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia.
  por: Determann, R, et al.
  Publicado em: (2005)
• Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects
  por: Al-Hamodi, Z., et al.
  Publicado em: (2011)
• Effect of plasminogen activator inhibitor-1 and tissue plasminogen activator polymorphisms on susceptibility to type 2 diabetes in malaysian subjects
  por: Al-Hamodi, Z., et al.
  Publicado em: (2012)
• Tissue-plasminogen activator effects on the phenotype of splenic myeloid cells in acute inflammation
  por: Célia Seillier, et al.
  Publicado em: (2024-02-01)
• Bronchoalveolar Activation of Coagulation and Inhibition of Fibrinolysis during Ventilator-Associated Lung Injury
  por: M. J. Schultz, et al.
  Publicado em: (2012-01-01)